Zomedica ZOMDF
OTC ZOMDF
$0.10 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Zomedica (ZOMDF) Asset Writedowns and Impairment (2020 - 2025)

Updated

Analysis

Zomedica (ZOMDF) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Zomedica 97.99 Mn -87.03 Mn 6.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 55.83 Mn
Jun 30, 2024 16.02 Mn
Mar 31, 2020 59,097.00
API Access

Zomedica Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY